结构优化的HPV16 E7/E6 mRNA-LPP通过瘤微环境重编程调节剂量节约的疗效
Shucai Sun1,2, Yao Deng3, Jiao Ren3
1Department of Nuclear Medicine, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Xinhua District, Shijiazhuang, Hebei, 050000, China.
Molecular biomedicine
|February 27, 2026
概括
这项研究开发了两种mRNA疫苗,用于HPV相关的癌症,使用脂聚复合 (LPP) 输送系统. 与非复制的mRNA (nr-mRNA) -LPP相比,自增强的mRNA (sa-mRNA) -LPP在较低剂量下显示出更高的功效和局部免疫反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗技术 疫苗技术 是一种
背景情况:
- 人类乳头瘤病毒 (HPV) 相关癌症的治疗疫苗面临来自免疫抑制瘤微环境的挑战.
- 现有的输送平台对HPV驱动的恶性瘤的有效性有限.
研究的目的:
- 为了比较两个mRNA疫苗策略,非复制mRNA (nr-mRNA) 和自我放大mRNA (sa-mRNA),通过脂聚复合 (LPP) 系统传递.
- 在HPV驱动的癌症模型中评估它们的有效性,并了解它们的免疫调节机制.
主要方法:
- nr-mRNA-LPP和sa-mRNA-LPP疫苗配方的设计和比较.
- 在TC-1小鼠模型中评估抗瘤免疫反应.
- 分析免疫细胞透,巨细胞再极化和瘤和淋巴细胞器官中的免疫激活.
主要成果:
- 这两种mRNA-LPP疫苗都激活了全身抗瘤免疫力,增加了CD8+T细胞和NK细胞的透率,并使巨细胞重聚到M1表型.
- sa-mRNA-LPP表现出优越的功效,在nr-mRNA-LPP的五分之一剂量下达到可比的疗效.
- 与nr-mRNA-LPP不同,sa-mRNA-LPP主要在瘤部位诱导局部免疫反应.
结论:
- 脂聚复合 (LPP) 平台有效地提供mRNA疫苗.
- sa-mRNA-LPP通过局部免疫重塑为HPV相关癌症提供了一种有效的剂量节约方法.
- 这些发现支持基于LPP的mRNA疫苗用于HPV驱动的癌症的临床转化.
相关概念视频
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
Mechanisms of Retrovirus-induced Cancers
7.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.1K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Mismatch Repair
6.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.8K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K


